Clinical Trial Update: First-line Chemotherapy for Recurrent Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for first-line chemotherapy in recurrent/persistent advanced cervical cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Carcinoma
• Persistent Advanced Cervical Carcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Lei Li | Conditions: Recurrent Cervical Carcinoma, Persistent Advanced Cervical Carcinoma | Phase 2 | Status: COMPLETED